Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. uri icon

authors

  • Ramsden, Nigel
  • Drewes, Gerard
  • Bantscheff, Marcus
  • Bard, Frederique
  • Ted M. Dawson, MD, PhD
  • Hopf, Carsten
  • Perrin, Jessica
  • Ren, Zhao
  • Lee, Byoung Dae
  • Zinn, Nico
  • Dawson, Valina L
  • Tam, Danny
  • Bova, Michael
  • Lang, Manja

publication date

  • January 1, 2011